Role of hypoxia-inducible factors (HIF) in the maintenance of sternness and malignancy of colorectal cancer

被引:77
|
作者
Vadde, Ramakrishna [1 ]
Vemula, Sarojamma [2 ]
Jinka, Rajeswari [3 ]
Merchant, Neha [4 ]
Bramhachari, Pallaval Veera [5 ]
Nagaraju, Ganji Purnachandra [4 ]
机构
[1] Yogi Vemana Univ, Dept Biotechnol & Bioinformat, Kadapa 516003, Andhra Prades, India
[2] Sri Venkateswara Med Coll, Dept Microbiol, Tirupati 517507, Andhra Prades, India
[3] Acharya Nagarjuna Univ, Dept Biochem, Guntur 522024, Andhra Prades, India
[4] Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA
[5] Krishna Univ, Dept Biotechnol, Machilipatnam 521001, Andhra Prades, India
关键词
Hypoxia; Hypoxia inducible factors; Cancer stem cells; Colon cancer; STEM-CELLS; EXPRESSION; CARCINOGENESIS; GROWTH; NICHE;
D O I
10.1016/j.critrevonc.2017.02.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypoxia is a condition of insufficient tissue oxygenation, which is observed during normal development as well as tumorigenesis and its response at the cellular level is primarily mediated through hypoxia inducible factors (HIFs). HIFs have a significant role in the maintenance of sternness in both stern cells as well as in cancer stem cells (CSC) by acting as transcription factors. The CSCs are proposed to be the driving force of colon tumorigenesis and malignancy. These HIFs play a significant role in a wide range of diseases including colon cancer. HIF's signaling functions with stemness, and maintaining Wnt/beta-catenin signaling pathways. Due to HIFs functional significance in sternness maintenance in malignancy, targeting HIFs might provide a new approach for development of new therapy for colon cancer. In this review, we will be briefing on the colon and its stem cells, various molecular signaling pathways involved in sternness preservation, and the role hypoxia and its HIFs in the maintenance of sternness in colon stem cells and colon cancer stem cells. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:22 / 27
页数:6
相关论文
共 50 条
  • [21] Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
    Wigerup, Caroline
    Pahlman, Sven
    Bexell, Daniel
    PHARMACOLOGY & THERAPEUTICS, 2016, 164 : 152 - 169
  • [22] Hypoxia-inducible factor (HIF) in crustaceans
    Terwilliger, N.
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 2007, 148 : S95 - S95
  • [23] Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
    Schoedel, Johannes
    Grampp, Steffen
    Maher, Eamonn R.
    Moch, Holger
    Ratcliffe, Peter J.
    Russo, Paul
    Mole, David R.
    EUROPEAN UROLOGY, 2016, 69 (04) : 646 - 657
  • [24] The Role of Hypoxia, Hypoxia-Inducible Factor (HIF), and VEGF in Retinal Angiomatous Proliferation
    Barben, Maya
    Samardzija, Marijana
    Grimm, Christian
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2018, 1074 : 177 - 183
  • [25] The hypoxia-inducible factor HIF as a new target in cancer research
    L'Allemain, G
    BULLETIN DU CANCER, 2002, 89 (03) : 257 - 260
  • [26] The role of hypoxia-inducible factors in cardiovascular diseases
    Yu, Baoqi
    Wang, Xia
    Song, Yanting
    Xie, Guomin
    Jiao, Shiyu
    Shi, Li
    Cao, Xuejie
    Han, Xinyao
    Qu, Aijuan
    PHARMACOLOGY & THERAPEUTICS, 2022, 238
  • [27] Hypoxia-inducible factor I (HIF-1) in cancer
    Quintero, M
    Mackenzie, N
    Brennan, PA
    EJSO, 2004, 30 (05): : 465 - 468
  • [28] Renoprotective Role of Hypoxia-Inducible Factors and the Mechanism
    Li, Qiu-Yu
    Liu, Fei
    Tang, Xiaoxiao
    Fu, Haidong
    Mao, Jianhua
    KIDNEY DISEASES, 2022, 8 (01) : 44 - 56
  • [29] Diabetic atherosclerosis: is there a role for the hypoxia-inducible factors?
    Pirri, Daniela
    Fragiadaki, Maria
    Evans, Paul C.
    BIOSCIENCE REPORTS, 2020, 40
  • [30] The role of hypoxia-inducible factors in metabolic diseases
    Gonzalez, Frank J.
    Xie, Cen
    Jiang, Changtao
    NATURE REVIEWS ENDOCRINOLOGY, 2018, 15 (01) : 21 - 32